BB-COPD

Beta Blockers for the Prevention of Acute Exacerbations of COPD (BB-COPD) is a multicenter, prospective, randomized, double-blind, placebo-controlled trial that will enroll 1,028 patients with at least moderately severe COPD over a three-year period and follow them at regular intervals for one year.